Infectious Diseases (except HIV/AIDS)

  1. SARS-CoV-2 Omicron Variant Infection of Individuals with High Titer Neutralizing Antibodies Post-3 rd mRNA Vaccine Dose

    1. Alexa J. Roeder
    2. Megan A. Koehler
    3. Sergei Svarovsky
    4. Paniz Jasbi
    5. Alim Seit-Nebi
    6. Maria J. Gonzalez-Moa
    7. John Vanderhoof
    8. Davis McKechnie
    9. Baylee A. Edwards
    10. Douglas F. Lake

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. SARS-CoV-2 Seroprevalence among Healthcare Workers after the First and Second Pandemic Waves

    1. Nathalie de Visscher
    2. Xavier Holemans
    3. Aline Gillain
    4. Anne Kornreich
    5. Raphael Lagasse
    6. Philippe Piette
    7. Manfredi Ventura
    8. Frédéric Thys

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. Development of a COVID-19 risk assessment model for participants at outdoor music festivals: evaluation of the validity and control measure effectiveness based on two actual events in Japan and Spain

    1. Michio Murakami
    2. Tsukasa Fujita
    3. Pinqi Li
    4. Seiya Imoto
    5. Tetsuo Yasutaka

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Different forms of superspreading lead to different outcomes: Heterogeneity in infectiousness and contact behavior relevant for the case of SARS-CoV-2

    1. Elise J. Kuylen
    2. Andrea Torneri
    3. Lander Willem
    4. Pieter J. K. Libin
    5. Steven Abrams
    6. Pietro Coletti
    7. Nicolas Franco
    8. Frederik Verelst
    9. Philippe Beutels
    10. Jori Liesenborgs
    11. Niel Hens

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Immunogenicity and safety of booster dose of S-268019-b or BNT162b2 in Japanese participants: An interim report of phase 2/3, randomized, observer-blinded, noninferiority study

    1. Masaharu Shinkai
    2. Takuhiro Sonoyama
    3. Akari Kamitani
    4. Risa Yokokawa Shibata
    5. Naomi M. Seki
    6. Shinya Omoto
    7. Masahiro Shinoda
    8. Takashi Sato
    9. Naoki Ishii
    10. Kenji Igarashi
    11. Mari Ariyasu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Spike mutations of the SARS-CoV-2 Omicron: more likely to occur in the epitopes

    1. Hu Li
    2. Zhiwei Chen
    3. Xiaoqing Liu
    4. Peng Hu

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults

    1. Suvimol Niyomnaitham
    2. Zheng Quan Toh
    3. Patimaporn Wongprompitak
    4. Laddawan Jansarikit
    5. Kanjana Srisutthisamphan
    6. Sompong Sapsutthipas
    7. Yuparat Jantraphakorn
    8. Natthakarn Mingngamsup
    9. Paul V Licciardi
    10. Kulkanya Chokephaibulkit

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. Evaluation of the role of home rapid antigen testing to determine isolation period after infection with SARS-CoV-2

    1. Lisa A. Cosimi
    2. Christina Kelly
    3. Samantha Esposito
    4. Scott Seitz
    5. Cole Sher-Jan
    6. Jacquelyn Turcinovic
    7. Kelley Friedman
    8. Michael Nashed
    9. Jesse Souweine
    10. Nicholas Fitzgerald
    11. Stacey Gabriel
    12. John H. Connor
    13. Deborah Hung

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Precision recruitment for high-risk participants in a COVID-19 research study

    1. Aziz M. Mezlini
    2. Eamon Caddigan
    3. Allison Shapiro
    4. Ernesto Ramirez
    5. Helena M. Kondow-McConaghy
    6. Justin Yang
    7. Kerry DeMarco
    8. Pejman Naraghi-Arani
    9. Luca Foschini

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis

    1. Faisal Salman Alshaikh
    2. Brian Godman
    3. Oula Nawaf Sindi
    4. R. Andrew Seaton
    5. Amanj Kurdi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 190 of 716 Next